This inventor holds 2 USPTO granted patents. Top assignee: Bristol-Myers Company. Active years: 1988-1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1990
Title: The Innovative Journey of Jacques Corbeil: A Pioneer in Carbapenem Synthesis
Introduction: Jacques Corbeil, an accomplished inventor based in Montreal, Canada, has made significant contributions to the field of pharmaceutical chemistry. With a total of two patents to his name, he has focused on developing advanced synthesis processes for key pharmaceutical intermediates, particularly carbapenems, which are essential for creating effective antibiotics.
Latest Patents: Corbeil's most recent inventions include innovative methods for synthesizing carbapenem intermediates with a high percentage of beta-yield. The first patent details a novel process that involves using intermediates of the formula ##STR1##, where R.sup.4 is ##STR2##. This process significantly aids in the production of 1-beta-alkyl carbapenems. The second patent presents a method utilizing novel silyl enol ether intermediates, which allows for the formation of azetidione thiolester intermediates necessary for crafting 1-beta-alkyl carbapenem antibiotics. Notably, by selecting specific groups for the R.sup.4 moiety, an impressive beta-yield of up to approximately 100% can be achieved.
Career Highlights: Jacques Corbeil's career is marked by his dedicated work at Bristol-Myers Squibb, a leading global biopharmaceutical company. His innovative research and development efforts have positioned him as a key figure in the advancement of antibiotic synthesis.
Collaborations: Throughout his career, Corbeil has collaborated with talented professionals such as Alain Martel and Jean-Paul Daris. These partnerships have facilitated knowledge exchange and contributed to the successful development of his patented processes.
Conclusion: Jacques Corbeil continues to make strides in the field of synthetic chemistry, particularly in the advancement of carbapenem synthesis. With his innovative approaches and collaborative spirit, he remains a vital contributor to the pharmaceutical industry, paving the way for the development of new and more effective antibiotic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile